UCB SA (UCBJY)
93.74
+2.57
(+2.82%)
USD |
OTCM |
Nov 22, 16:00
UCB Price to Book Value: 3.706 for Nov. 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
November 22, 2024 | 3.706 |
November 21, 2024 | 3.605 |
November 20, 2024 | 3.545 |
November 19, 2024 | 3.438 |
November 18, 2024 | 3.465 |
November 15, 2024 | 3.476 |
November 14, 2024 | 3.699 |
November 13, 2024 | 3.808 |
November 12, 2024 | 3.818 |
November 11, 2024 | 3.885 |
November 08, 2024 | 3.921 |
November 07, 2024 | 3.883 |
November 06, 2024 | 3.866 |
November 05, 2024 | 3.898 |
November 04, 2024 | 3.848 |
November 01, 2024 | 3.876 |
October 31, 2024 | 3.794 |
October 30, 2024 | 3.839 |
October 29, 2024 | 3.834 |
October 28, 2024 | 3.800 |
October 25, 2024 | 3.807 |
October 24, 2024 | 3.778 |
October 23, 2024 | 3.702 |
October 22, 2024 | 3.666 |
October 21, 2024 | 3.726 |
Date | Value |
---|---|
October 18, 2024 | 3.727 |
October 17, 2024 | 3.788 |
October 16, 2024 | 3.699 |
October 15, 2024 | 3.722 |
October 14, 2024 | 3.741 |
October 11, 2024 | 3.693 |
October 10, 2024 | 3.626 |
October 09, 2024 | 3.617 |
October 08, 2024 | 3.623 |
October 07, 2024 | 3.576 |
October 04, 2024 | 3.624 |
October 03, 2024 | 3.599 |
October 02, 2024 | 3.587 |
October 01, 2024 | 3.635 |
September 30, 2024 | 3.566 |
September 27, 2024 | 3.554 |
September 26, 2024 | 3.624 |
September 25, 2024 | 3.704 |
September 24, 2024 | 3.705 |
September 23, 2024 | 3.594 |
September 20, 2024 | 3.597 |
September 19, 2024 | 3.536 |
September 18, 2024 | 3.518 |
September 17, 2024 | 3.485 |
September 16, 2024 | 3.620 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.347
Minimum
Sep 22 2022
3.921
Maximum
Nov 08 2024
2.184
Average
2.122
Median
Price to Book Value Benchmarks
Galapagos NV | 0.5592 |
Mithra Pharmaceuticals SA | -- |
Nyxoah SA | 2.558 |
Celyad Oncology SA | -- |
MDxHealth SA | 5.476 |
Price to Book Value Related Metrics
PE Ratio | 142.72 |
PS Ratio | 6.235 |
Price to Free Cash Flow | 59.76 |
Price | 93.74 |
Earnings Yield | 0.70% |
Market Cap | 35.57B |
Operating PE Ratio | 71.44 |
Normalized PE Ratio | 143.60 |